CTRI/2019/04/018866尚未招募不适用
Comparative Evaluation of the Therapeutic Efficacy of Dermabrasion and Narrowband Ultraviolet B, with and without Topical Autologous Platelet Rich Plasma in Stable Vitiligo: An Assessor Blinded Randomized Clinical Trial
DR KINGSHUK CHATTERJEE1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2019年5月25日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- 2. Vitiligo Area Scoring Index (VASI)
研究概览
简要总结
This is a clinical trial to compare the efficacy and safety of Dermabrasion followed by Autologous Platelet Rich Plasma followed by NBUVB versus Dermabrasion followed by NBUVB in stable vitiligo.
研究设计
- 研究类型
- Interventional
- 分配方式
- Computer generated randomization
- 盲法
- Outcome Assessor Blinded
入排标准
- 年龄范围
- 18.00 Year(s) 至 90.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients/ Legally authorized representative (LAR) providing written informed consent towards participation in the study
- •All patients of Vitiligo with disease stability for last three (3) months
- •Patients with Vitiligo bilaterally symmetrical in distribution
- •Patients unresponsive to medical treatment or photo therapy
- •Patients older than 18 years.
排除标准
- •Vitiligo involving head and neck, face, intertriginous areas, hands and feet
- •Pregnant and Lactating female
- •Patients with Haemoglobin < 10 gm/dl
- •Patients with Platelet count < 105/UL
- •Patients with bleeding diathesis
- •Patients with active infection
- •Patients with history of Keloid/ Hypertrophic scars
- •Patients with history of Koebnerization
- •Patients with Chronic liver disease
- •Patients on chemotherapy, anti-coagulation therapy and antiplatelet agent.
结局指标
主要结局
2. Vitiligo Area Scoring Index (VASI)
时间窗: Baseline, every 2 weeks of treatment and after 3 months
1. Vitiligo European Task Force Assessment (VETF)
时间窗: Baseline, every 2 weeks of treatment and after 3 months
次要结局
- 1. Scoring system of Repigmentation(2. Patient Satisfaction)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Comparative evaluation of efficacy of multiple treatments in the treatment of vitiligovitiligo.disorder of pigmentationIRCT138904081159N6Vice chancellor for research, Tehran University of Medical Sciences70
Unknown
不适用
Evaluation of the Efficacy and the Cutaneous Acceptability of a Dermocosmetic Product in the Repigmentation of VitiligoVitiligoNCT04171427Laboratoire Dermatologique ACM12
尚未招募
不适用
To assess the effectiveness and safety of dermabrasion followed by tacrolimus and dermabrasion followed by dinoprostone in stable vitiligo patients.CTRI/2025/04/083785Dr Monika V52
已完成
4 期
Comparison of Two Different Surgical Approaches To Increase Peri-Implant Mucosa ThicknessTooth LossPeri-implant Mucosa DefectNCT02450383University of Iowa20
已完成
4 期
To Evaluate and compare effect and skin safety of Clobetasol gel (Clobetasol Propionate USP 0.05% w/w) and Clobetasol Cream (Clobetasol Propionate BP 0.05% w/w) in patients with mild to moderate psoriasisCTRI/2013/02/003430Curatio Healthcare Pvt Ltd36